Ketotifeno Codramol (Ketotifen Hydrogen Fumarate)

Ketotifen hydrogen fumarate works by blocking H1 histamine receptors on the surface of ocular mast cells and by stabilising those cells to prevent degranulation. This dual mechanism reduces the release of histamine and other inflammatory mediators, thereby decreasing vascular permeability, itching and swelling in the conjunctiva and cornea.

The dosage of Ketotifeno Codramol is determined by the prescribing clinician based on the severity of the condition and patient factors. Typically, one drop is instilled into the affected eye(s) as directed, but the exact frequency and duration should follow the healthcare professional’s instructions.

Safety data for ketotifen in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant. Pregnant or nursing women should discuss use with their healthcare provider before starting therapy.

To order Ketotifeno Codramol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketotifeno Codramol combines H1‑receptor antagonism with mast‑cell stabilisation, offering both immediate symptom relief and longer‑term control of inflammation. Compared with agents such as olopatadine, which are primarily H1 antagonists, ketotifen may provide added benefit in chronic conditions where mast‑cell degranulation plays a major role.

Ketotifeno Codramol should be stored at room temperature, below 25 °C, in its original container. Protect the product from excessive light and moisture. Do not freeze. Keep the bottle tightly closed when not in use to maintain sterility and potency.

The medication is administered as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac of the affected eye(s). The eye should be closed gently for a few seconds to allow absorption, and contact lenses should be removed before dosing.

Serious risks, although rare, include severe ocular inflammation, corneal ulceration, allergic reactions that may cause eyelid swelling, anaphylaxis, and sudden loss of vision. Any signs of worsening eye condition, intense pain, or visual changes should prompt immediate medical attention.

Ketotifeno Codramol should be avoided by individuals with a known hypersensitivity to ketotifen or any excipients in the formulation. It is also contraindicated in patients with active severe ocular infections until the infection is resolved, and caution is advised in those with uncontrolled glaucoma or intra‑ocular pressure issues.